000 | 01875 a2200505 4500 | ||
---|---|---|---|
005 | 20250517151635.0 | ||
264 | 0 | _c20180306 | |
008 | 201803s 0 0 eng d | ||
022 | _a1873-3913 | ||
024 | 7 |
_a10.1016/j.cellsig.2017.04.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAnsari, Mushtaq A | |
245 | 0 | 0 |
_aAdenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T _h[electronic resource] |
260 |
_bCellular signalling _c08 2017 |
||
300 |
_a14-24 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAutism Spectrum Disorder _ximmunology |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aForkhead Transcription Factors _xmetabolism |
650 | 0 | 4 | _aGrooming |
650 | 0 | 4 |
_aInterleukin-10 _xmetabolism |
650 | 0 | 4 |
_aInterleukin-17 _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNuclear Receptor Subfamily 1, Group F, Member 3 _xmetabolism |
650 | 0 | 4 |
_aPhenethylamines _xpharmacology |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aReceptor, Adenosine A2A _xmetabolism |
650 | 0 | 4 |
_aSTAT3 Transcription Factor _xgenetics |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTh17 Cells _xdrug effects |
650 | 0 | 4 |
_aTriazoles _xpharmacology |
700 | 1 | _aNadeem, Ahmed | |
700 | 1 | _aAttia, Sabry M | |
700 | 1 | _aBakheet, Saleh A | |
700 | 1 | _aRaish, Mohammad | |
700 | 1 | _aAhmad, Sheikh F | |
773 | 0 |
_tCellular signalling _gvol. 36 _gp. 14-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cellsig.2017.04.014 _zAvailable from publisher's website |
999 |
_c27109322 _d27109322 |